Pancreatic Intraepithelial Neoplasia Revealed by Diffusion-Tensor MRI.

Autor: Bilreiro C; From the Radiology Department, Champalimaud Foundation, Lisbon, Portugal (C.B., C.M.); Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal (C.B., F.F.F., R.H., C.C., A.I., M.C.-M., T.C., C.M., N.S.); Nova Medical School, Lisbon, Portugal (C.B.); i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal (R.V.S.); and Pathology Department, Champalimaud Foundation, Lisbon, Portugal (M.C.-M.)., Fernandes FF, Simões RV, Henriques R, Chavarrías C, Ianus A, Castillo-Martin M, Carvalho T, Matos C, Shemesh N

Publikováno v: Investigative radiology [Invest Radiol] 2024 Dec 13. Date of Electronic Publication: 2024 Dec 13.

Varicocele embolization with glue and coils: A single center experience

Autor: Bilreiro, C., Donato, P., Costa, J.F., Agostinho, A., Carvalheiro, V., Caseiro-Alves, F.

Publikováno v: In Diagnostic and Interventional Imaging July-August 2017 98(7-8):529-534

Analysis of domain shift in whole prostate gland, zonal and lesions segmentation and detection, using multicentric retrospective data.

Autor: Rodrigues NM; Computational Clinical Imaging Group, Champalimaud Foundation, Portugal; LASIGE, Faculty of Sciences, University of Lisbon, Portugal. Electronic address: nmrodrigues@fc.ul.pt., Almeida JG; LASIGE, Faculty of Sciences, University of Lisbon, Portugal. Electronic address: jose.almeida@research.fchampalimaud.org., Verde ASC; LASIGE, Faculty of Sciences, University of Lisbon, Portugal., Gaivão AM; Radiology Department, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Bilreiro C; Radiology Department, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Santiago I; Radiology Department, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Ip J; Radiology Department, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Belião S; Radiology Department, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Moreno R; Computational Clinical Imaging Group, Champalimaud Foundation, Portugal., Matos C; Computational Clinical Imaging Group, Champalimaud Foundation, Portugal., Vanneschi L; NOVA Information Management School (NOVA IMS), Universidade Nova de Lisboa, Campus de Campolide, 1070-312 Lisboa, Portugal., Tsiknakis M; Institute of Computer Science, Foundation for Research and Technology Hellas (FORTH), GR 700 13, Heraklion, Greece; Department of Electrical and Computer Engineering, Hellenic Mediterranean University, GR 710 04, Heraklion, Greece., Marias K; Department of Electrical and Computer Engineering, Hellenic Mediterranean University, GR 710 04, Heraklion, Greece; Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation for Research and Technology - Hellas (FORTH), Heraklion, Greece., Regge D; Department of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, Candiolo, Turin 10060, Italy; Department of Surgical Sciences, University of Turin, Turin 10124, Italy., Silva S; LASIGE, Faculty of Sciences, University of Lisbon, Portugal., Papanikolaou N; Computational Clinical Imaging Group, Champalimaud Foundation, Portugal; Department of Radiology, Royal Marsden Hospital, Sutton, UK.

Publikováno v: Computers in biology and medicine [Comput Biol Med] 2024 Mar; Vol. 171, pp. 108216. Date of Electronic Publication: 2024 Mar 02.

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment.

Autor: Lopes R; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Caetano J; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Hemato-Oncology Department, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medical Sciences, NOVA Medical School (NMS), Lisbon, Portugal., Barahona F; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medical Sciences, NOVA Medical School (NMS), Lisbon, Portugal., Pestana C; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Centre of Statistics and Its Applications, Faculty of Sciences, University of Lisbon, Lisbon, Portugal., Ferreira BV; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Hemato-Oncology Department, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medical Sciences, NOVA Medical School (NMS), Lisbon, Portugal., Lourenço D; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Queirós AC; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal., Bilreiro C; Faculty of Medical Sciences, NOVA Medical School (NMS), Lisbon, Portugal.; Neural Plasticity and Neural Activity Laboratory, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Radiology Department, Champalimaud Foundation, Lisbon, Portugal., Shemesh N; Neural Plasticity and Neural Activity Laboratory, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal., Beck HC; Centre for Clinical Proteomics, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark., Carvalho AS; Computational and Experimental Biology, Chronic Diseases Research Centre (CEDOC); NOVA Medical School (NMS), Lisbon, Portugal., Matthiesen R; Computational and Experimental Biology, Chronic Diseases Research Centre (CEDOC); NOVA Medical School (NMS), Lisbon, Portugal., Bogen B; Institute of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Costa-Silva B; Systems Oncology, Champalimaud Physiology and Cancer Programme, Champalimaud Foundation, Lisbon, Portugal., Serre K; Molecular Medicine Institute-Laço Hub, Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal., Carneiro EA; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal., João C; Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.; Hemato-Oncology Department, Champalimaud Foundation, Lisbon, Portugal.; Faculty of Medical Sciences, NOVA Medical School (NMS), Lisbon, Portugal.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jul 07; Vol. 13, pp. 909880. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).

Effective bowel motion reduction in mouse abdominal MRI using hyoscine butylbromide.

Autor: Bilreiro C; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.; Radiology Department, Champalimaud Clinical Centre, Lisbon, Portugal.; Nova Medical School, Lisbon, Portugal., Fernandes FF; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal., Andrade L; Radiology Department, Champalimaud Clinical Centre, Lisbon, Portugal., Chavarrías C; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal., Simões RV; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal., Matos C; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.; Radiology Department, Champalimaud Clinical Centre, Lisbon, Portugal., Shemesh N; Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.

Publikováno v: Magnetic resonance in medicine [Magn Reson Med] 2021 Oct; Vol. 86 (4), pp. 2146-2155. Date of Electronic Publication: 2021 May 12.